Hong Liu
Research Subjects
Hong Liu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Chengyuan Liang
School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Xixian New Area Fenghou Original Medical Technology Co., Ltd., Xi'an, 712000, China
4 shared publications Han Li
School of Food and Bioengineering, Shaanxi University of Science & Technology, Xi'an 710021, PR China
4 shared publicationsLei Tian
School of Food and Bioengineering, Shaanxi University of Science & Technology, Xi'an 710021, PR China; College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an 710021, PR China
3 shared publicationsMinge Wan
School of Medicine and Pharmacy, Shaanxi University of Business & Commerce, Xi'an 712046, PR China
3 shared publicationsJingyi Li
School of Food and Bioengineering, Shaanxi University of Science & Technology, Xi'an 710021, PR China
2 shared publicationsLiang Xin
School of Food and Bioengineering, Shaanxi University of Science & Technology, Xi'an 710021, PR China
2 shared publications
Latest Publications
- 1 August 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 220, 113451
Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia
- 1 August 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 220, 113451
Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia
- Open Access
- 1 May 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 137, 111313
An update review of emerging small-molecule therapeutic options for COVID-19
- 1 May 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 137, 111313
Open AccessAn update review of emerging small-molecule therapeutic options for COVID-19
- 1 March 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 213, 113201
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
- 1 March 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 213, 113201
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic